Chemokines are important in HSE development in the CNS but underlying regulatory events are unknown. Two-hybrid binding assays identified that intercellular adhesion molecule 5 (ICAM-5), an immune modulator in the CNS, interacted with neurovirulence factor, UOL, of HSV-1. Viral load and interleukin levels were similar in UOL deletion virus (ΔUOL), and wild type virus infected mouse brains. However, higher numbers of lymphocytes, but unaltered soluble ICAM-5 and chemokine levels were detected in ΔUOL infected mouse brains. In contrast, lower lymphocyte numbers, reduced soluble ICAM-5, and higher chemokine levels were detected in wild type virus infected brains. Our results suggest that ICAM-5 plays a critical role in modulating chemokine production in the CNS.
Introduction
Herpes simplex encephalitis (HSE) is induced by herpes simplex virus type 1 (HSV-1) infection, a neurotropic double-stranded DNA virus that belongs to the herpes viridae family. HSE is the commonest fatal sporadic encephalitis in humans (Whitley, 1990) . While the exact incidence of HSE is not known, it has been estimated that about 2000 cases occur annually in the United States (Johnston, 1998) . Serological studies estimate that over five billion people are presently infected with HSV-1 worldwide (Whitley, 2001) , thus the actual incidence is probably an underestimate. HSE is a devastating disease and more than 70% of untreated patients die with only 2.5% of surviving patients returning to normal neurological function (Whitley and Roizman, 2001) . In adults, HSV-1 accounts for 95% of all fatal cases of sporadic HSE and usually results from reactivation of the latent virus.
HSV-1 is one of the most prevalent viruses in humans, 90% of normal people show past exposure to the virus (Whitley and Roizman, 2001 ). More than 33% of HSV infections of the world population are evident as recurrent (Whitley et al., 1998) . Upon primary infection with viral replication, HSV-1 viral particles may travel through axons (Whitley and Roizman, 2001 ) by anterograde flow to sensory neuron in trigeminal ganglion, where viral replication occurs briefly and become latent in the sensory neurons for life. Latent HSV-1 is periodically reactivated, either spontaneously or following various triggering events such as trauma, sunlight, and stress, to cause blisters in the mouths and lips, and occasionally HSE in the brain (Whitley and Roizman, 2001) .
HSV-1 infects via mucosal surfaces or damaged skin. Thus, ocular infection with HSV-1 can induce HSE in infected animals (Perng et al., 1994; Perng et al., 2001) . The high mortality rates and the potential burden of neurological disorder in recovered individuals in HSE, has lead to extensive studies of the neuropathogenesis of HSE, and numerous factors associated with HSE have been suggested, such as viral load or strains of the virus, imbalances of the immune response, the individual's genetic background, nutritional status, or cytokine and chemokine storms (Aurelius et al., 1994; Baringer, 2008; Rosler et al., 1998; Wuest and Carr, 2008) . All in all, the information collected indicates that the main feature of HSE is the propensity of the disease for the frontotemporal region (Johnston, 1998) and that infiltration of immune cells into the brain during HSV-1 infection causes as much damage as the virus itself (Chan et al., 1989) . Cytokines, including chemokines, produced from resident immune functional cells or from infiltrating immune cells have been implicated in playing an important role in the pathogenesis of HSE (Aurelius et al., 1994; Rosler et al., 1998) . However, differentiation of viral tropism from immune tropism has not been well delineated and the exact mechanism(s) by which modulation of these cytokines lead to the development of HSE is largely unknown.
Several genes or gene products from HSV-1 have been associated with neurovirulence in infected animals (Stevens, 1987) even though Journal of Neuroimmunology 213 (2009) 12-19 
